| scholarly article | Q13442814 |
| P50 | author | Yili Fang | Q96607409 |
| P2093 | author name string | Fang Li | |
| Feng Wang | |||
| Zhonghua Zhao | |||
| Zhigang Zhang | |||
| Huijuan Wu | |||
| Jian-Kang Chen | |||
| Chenyang Qi | |||
| Xing Mao | |||
| P2860 | cites work | TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1 | Q24293153 |
| Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34 | Q28245141 | ||
| Identification and characterization of the tuberous sclerosis gene on chromosome 16 | Q28257738 | ||
| AMPK: a nutrient and energy sensor that maintains energy homeostasis | Q29615410 | ||
| Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
| Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis | Q33182344 | ||
| ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway | Q33560337 | ||
| TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review | Q33617062 | ||
| Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis | Q34009330 | ||
| Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome | Q34321198 | ||
| Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis | Q34573001 | ||
| Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis | Q35044713 | ||
| Phosphorylation of ribosomal protein S6 mediates compensatory renal hypertrophy | Q35132442 | ||
| EGFR signaling promotes TGFβ-dependent renal fibrosis | Q35715849 | ||
| Targeting AMPK for cancer prevention and treatment | Q35781311 | ||
| Renal angiomyolipomata. | Q35870422 | ||
| mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking | Q36574743 | ||
| Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway | Q36685458 | ||
| Blocking rpS6 Phosphorylation Exacerbates Tsc1 Deletion-Induced Kidney Growth | Q36746057 | ||
| Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. | Q37092766 | ||
| AMP-Activated Protein Kinase α 2 Isoform Suppression in Primary Breast Cancer Alters AMPK Growth Control and Apoptotic Signaling | Q37094565 | ||
| Survivin mediates renal proximal tubule recovery from AKI. | Q37340201 | ||
| Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis Complex | Q37721031 | ||
| The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling | Q37831801 | ||
| Activation of AMP-activated protein kinase inhibits ER stress and renal fibrosis | Q38431719 | ||
| Metformin: An anti-diabetic drug to fight cancer | Q38976526 | ||
| Treatment of Renal Angiomyolipoma and Other Hamartomas in Patients with Tuberous Sclerosis Complex. | Q39182861 | ||
| Tuberous sclerosis complex: Recent advances in manifestations and therapy. | Q39408346 | ||
| Protection of NRK-52E cells, a rat renal proximal tubular cell line, from chemical-induced apoptosis by overexpression of a mitochondrial glutathione transporter | Q40696111 | ||
| Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells | Q41000352 | ||
| The role of metformin and resveratrol in the prevention of hypoxia-inducible factor 1α accumulation and fibrosis in hypoxic adipose tissue | Q41762813 | ||
| Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis | Q42021296 | ||
| S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy | Q42454439 | ||
| Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production | Q42522825 | ||
| Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice | Q42715172 | ||
| Everolimus in patients with autosomal dominant polycystic kidney disease. | Q43004249 | ||
| Sirolimus and kidney growth in autosomal dominant polycystic kidney disease | Q43004251 | ||
| Prevalence of tuberous sclerosis estimated by capture-recapture analysis. | Q45186933 | ||
| Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex | Q47094384 | ||
| Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study | Q47749237 | ||
| Metformin ameliorates the progression of atherosclerosis via suppressing macrophage infiltration and inflammatory responses in rabbits | Q49923266 | ||
| The protective effect of betulinic acid (BA) diabetic nephropathy on streptozotocin (STZ)-induced diabetic rats. | Q51240238 | ||
| Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis. | Q51245616 | ||
| Paeoniflorin ameliorates renal function in cyclophosphamide-induced mice via AMPK suppressed inflammation and apoptosis. | Q51335598 | ||
| Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway. | Q52583849 | ||
| Nrf2 attenuates inflammatory response in COPD/emphysema: Crosstalk with Wnt3a/β-catenin and AMPK pathways. | Q52586338 | ||
| Oregonin inhibits inflammation and protects against barrier disruption in intestinal epithelial cells. | Q52691217 | ||
| Metformin prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction. | Q53470041 | ||
| Protectin DX attenuates LPS-induced inflammation and insulin resistance in adipocytes via AMPK-mediated suppression of the NFκB pathway. | Q54119118 | ||
| Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation. | Q54121333 | ||
| Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer | Q59083181 | ||
| Tuberous sclerosis complex | Q89288858 | ||
| Metformin reverses established lung fibrosis in a bleomycin model | Q89393778 | ||
| Renal disease in tuberous sclerosis complex: pathogenesis and therapy | Q91555958 | ||
| P921 | main subject | metformin | Q19484 |
| P304 | page(s) | 52 | |
| P577 | publication date | 2020-06-15 | |
| P1433 | published in | Cell Death Discovery | Q27726740 |
| P1476 | title | Metformin effectively treats Tsc1 deletion-caused kidney pathology by upregulating AMPK phosphorylation | |
| P478 | volume | 6 |
Search more.